The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune and molecular determinants of response to neoadjuvant chemotherapy in inflammatory breast cancer.
 
Sangeetha Meda Reddy
No Relationships to Disclose
 
Jennifer Ann Wargo
Leadership - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Honoraria - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Consulting or Advisory Role - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Speakers' Bureau - Novartis; Genetech
Research Funding - BMS; Genetech; Novartis; GSK (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
 
Alexandre Reuben
No Relationships to Disclose
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics
 
Jason Roszik
No Relationships to Disclose
 
James M. Reuben
No Relationships to Disclose
 
Wendy A. Woodward
No Relationships to Disclose
 
Naoto T. Ueno
No Relationships to Disclose
 
Savitri Krishnamurthy
No Relationships to Disclose
 
Elizabeth Ann Mittendorf
Consulting or Advisory Role - Amgen; OBI Pharma
Research Funding - Antigen Express (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst)